Caffeine extends life span, improves healthspan, and delays age-associated pathology in Caenorhabditis elegans
The longevity of an organism is influenced by both genetic and environmental factors. With respect to genetic factors, a significant effort is being made to identify pharmacological agents that extend life span by targeting pathways with a defined role in the aging process. On the environmental side...
Saved in:
| Published in | Longevity & healthspan Vol. 1; no. 1; p. 9 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
01.12.2012
BioMed Central |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The longevity of an organism is influenced by both genetic and environmental factors. With respect to genetic factors, a significant effort is being made to identify pharmacological agents that extend life span by targeting pathways with a defined role in the aging process. On the environmental side, the molecular mechanisms responsible for the positive influence of interventions such as dietary restriction are being explored. The environment experienced by humans in modern societies already contains countless compounds that may influence longevity. Understanding the role played by common compounds that substantially affect the aging process will be critical for predicting and interpreting the outcome of introducing new interventions. Caffeine is the most widely used psychoactive drug worldwide. Prior studies in flies, worms, and mice indicate that caffeine may positively impact age-associated neurodegenerative pathology, such as that observed in Alzheimer's disease.
Here we report that caffeine is capable of extending life span and improving healthspan in Caenorhabditis elegans, a finding that is in agreement with a recently published screen looking for FDA-approved compounds capable of extending worm life span. Life span extension using caffeine displays epistatic interaction with two known longevity interventions: dietary restriction and reduced insulin signaling. Caffeine treatment also delays pathology in a nematode model of polyglutamine disease.
The identification of caffeine as a relevant factor in aging and healthspan in worms, combined with prior work in both humans and rodents linking caffeine consumption to reduced risk of age-associated disease, suggests that caffeine may target conserved longevity pathways. Further, it may be important to consider caffeine consumption when developing clinical interventions, particularly those designed to mimic dietary restriction or modulate insulin/IGF-1-like signaling. The positive impact of caffeine on a worm model of polyglutamine disease suggests that chronic caffeine consumption may generally enhance resistance to proteotoxic stress and may be relevant to assessing risk and developing treatments for human diseases like Alzheimer's and Huntington's disease. Future work addressing the relevant targets of caffeine in models of aging and healthspan will help to clarify the underlying mechanisms and potentially identify new molecular targets for disease intervention. |
|---|---|
| AbstractList | Background The longevity of an organism is influenced by both genetic and environmental factors. With respect to genetic factors, a significant effort is being made to identify pharmacological agents that extend life span by targeting pathways with a defined role in the aging process. On the environmental side, the molecular mechanisms responsible for the positive influence of interventions such as dietary restriction are being explored. The environment experienced by humans in modern societies already contains countless compounds that may influence longevity. Understanding the role played by common compounds that substantially affect the aging process will be critical for predicting and interpreting the outcome of introducing new interventions. Caffeine is the most widely used psychoactive drug worldwide. Prior studies in flies, worms, and mice indicate that caffeine may positively impact age-associated neurodegenerative pathology, such as that observed in Alzheimer's disease. Results Here we report that caffeine is capable of extending life span and improving healthspan in Caenorhabditis elegans, a finding that is in agreement with a recently published screen looking for FDA-approved compounds capable of extending worm life span. Life span extension using caffeine displays epistatic interaction with two known longevity interventions: dietary restriction and reduced insulin signaling. Caffeine treatment also delays pathology in a nematode model of polyglutamine disease. Conclusions The identification of caffeine as a relevant factor in aging and healthspan in worms, combined with prior work in both humans and rodents linking caffeine consumption to reduced risk of age-associated disease, suggests that caffeine may target conserved longevity pathways. Further, it may be important to consider caffeine consumption when developing clinical interventions, particularly those designed to mimic dietary restriction or modulate insulin/IGF-1-like signaling. The positive impact of caffeine on a worm model of polyglutamine disease suggests that chronic caffeine consumption may generally enhance resistance to proteotoxic stress and may be relevant to assessing risk and developing treatments for human diseases like Alzheimer's and Huntington's disease. Future work addressing the relevant targets of caffeine in models of aging and healthspan will help to clarify the underlying mechanisms and potentially identify new molecular targets for disease intervention. Keywords: Aging, Life span, Longevity, Healthspan, Worms, Caffeine, Proteotoxicity, Neurodegeneration The longevity of an organism is influenced by both genetic and environmental factors. With respect to genetic factors, a significant effort is being made to identify pharmacological agents that extend life span by targeting pathways with a defined role in the aging process. On the environmental side, the molecular mechanisms responsible for the positive influence of interventions such as dietary restriction are being explored. The environment experienced by humans in modern societies already contains countless compounds that may influence longevity. Understanding the role played by common compounds that substantially affect the aging process will be critical for predicting and interpreting the outcome of introducing new interventions. Caffeine is the most widely used psychoactive drug worldwide. Prior studies in flies, worms, and mice indicate that caffeine may positively impact age-associated neurodegenerative pathology, such as that observed in Alzheimer's disease. Here we report that caffeine is capable of extending life span and improving healthspan in Caenorhabditis elegans, a finding that is in agreement with a recently published screen looking for FDA-approved compounds capable of extending worm life span. Life span extension using caffeine displays epistatic interaction with two known longevity interventions: dietary restriction and reduced insulin signaling. Caffeine treatment also delays pathology in a nematode model of polyglutamine disease. The identification of caffeine as a relevant factor in aging and healthspan in worms, combined with prior work in both humans and rodents linking caffeine consumption to reduced risk of age-associated disease, suggests that caffeine may target conserved longevity pathways. Further, it may be important to consider caffeine consumption when developing clinical interventions, particularly those designed to mimic dietary restriction or modulate insulin/IGF-1-like signaling. The positive impact of caffeine on a worm model of polyglutamine disease suggests that chronic caffeine consumption may generally enhance resistance to proteotoxic stress and may be relevant to assessing risk and developing treatments for human diseases like Alzheimer's and Huntington's disease. Future work addressing the relevant targets of caffeine in models of aging and healthspan will help to clarify the underlying mechanisms and potentially identify new molecular targets for disease intervention. The longevity of an organism is influenced by both genetic and environmental factors. With respect to genetic factors, a significant effort is being made to identify pharmacological agents that extend life span by targeting pathways with a defined role in the aging process. On the environmental side, the molecular mechanisms responsible for the positive influence of interventions such as dietary restriction are being explored. The environment experienced by humans in modern societies already contains countless compounds that may influence longevity. Understanding the role played by common compounds that substantially affect the aging process will be critical for predicting and interpreting the outcome of introducing new interventions. Caffeine is the most widely used psychoactive drug worldwide. Prior studies in flies, worms, and mice indicate that caffeine may positively impact age-associated neurodegenerative pathology, such as that observed in Alzheimer's disease. Here we report that caffeine is capable of extending life span and improving healthspan in Caenorhabditis elegans, a finding that is in agreement with a recently published screen looking for FDA-approved compounds capable of extending worm life span. Life span extension using caffeine displays epistatic interaction with two known longevity interventions: dietary restriction and reduced insulin signaling. Caffeine treatment also delays pathology in a nematode model of polyglutamine disease. The identification of caffeine as a relevant factor in aging and healthspan in worms, combined with prior work in both humans and rodents linking caffeine consumption to reduced risk of age-associated disease, suggests that caffeine may target conserved longevity pathways. Further, it may be important to consider caffeine consumption when developing clinical interventions, particularly those designed to mimic dietary restriction or modulate insulin/IGF-1-like signaling. The positive impact of caffeine on a worm model of polyglutamine disease suggests that chronic caffeine consumption may generally enhance resistance to proteotoxic stress and may be relevant to assessing risk and developing treatments for human diseases like Alzheimer's and Huntington's disease. Future work addressing the relevant targets of caffeine in models of aging and healthspan will help to clarify the underlying mechanisms and potentially identify new molecular targets for disease intervention. BACKGROUND: The longevity of an organism is influenced by both genetic and environmental factors. With respect to genetic factors, a significant effort is being made to identify pharmacological agents that extend life span by targeting pathways with a defined role in the aging process. On the environmental side, the molecular mechanisms responsible for the positive influence of interventions such as dietary restriction are being explored. The environment experienced by humans in modern societies already contains countless compounds that may influence longevity. Understanding the role played by common compounds that substantially affect the aging process will be critical for predicting and interpreting the outcome of introducing new interventions. Caffeine is the most widely used psychoactive drug worldwide. Prior studies in flies, worms, and mice indicate that caffeine may positively impact age-associated neurodegenerative pathology, such as that observed in Alzheimer's disease. RESULTS: Here we report that caffeine is capable of extending life span and improving healthspan in Caenorhabditis elegans, a finding that is in agreement with a recently published screen looking for FDA-approved compounds capable of extending worm life span. Life span extension using caffeine displays epistatic interaction with two known longevity interventions: dietary restriction and reduced insulin signaling. Caffeine treatment also delays pathology in a nematode model of polyglutamine disease. CONCLUSIONS: The identification of caffeine as a relevant factor in aging and healthspan in worms, combined with prior work in both humans and rodents linking caffeine consumption to reduced risk of age-associated disease, suggests that caffeine may target conserved longevity pathways. Further, it may be important to consider caffeine consumption when developing clinical interventions, particularly those designed to mimic dietary restriction or modulate insulin/IGF-1-like signaling. The positive impact of caffeine on a worm model of polyglutamine disease suggests that chronic caffeine consumption may generally enhance resistance to proteotoxic stress and may be relevant to assessing risk and developing treatments for human diseases like Alzheimer's and Huntington's disease. Future work addressing the relevant targets of caffeine in models of aging and healthspan will help to clarify the underlying mechanisms and potentially identify new molecular targets for disease intervention. BACKGROUNDThe longevity of an organism is influenced by both genetic and environmental factors. With respect to genetic factors, a significant effort is being made to identify pharmacological agents that extend life span by targeting pathways with a defined role in the aging process. On the environmental side, the molecular mechanisms responsible for the positive influence of interventions such as dietary restriction are being explored. The environment experienced by humans in modern societies already contains countless compounds that may influence longevity. Understanding the role played by common compounds that substantially affect the aging process will be critical for predicting and interpreting the outcome of introducing new interventions. Caffeine is the most widely used psychoactive drug worldwide. Prior studies in flies, worms, and mice indicate that caffeine may positively impact age-associated neurodegenerative pathology, such as that observed in Alzheimer's disease. RESULTSHere we report that caffeine is capable of extending life span and improving healthspan in Caenorhabditis elegans, a finding that is in agreement with a recently published screen looking for FDA-approved compounds capable of extending worm life span. Life span extension using caffeine displays epistatic interaction with two known longevity interventions: dietary restriction and reduced insulin signaling. Caffeine treatment also delays pathology in a nematode model of polyglutamine disease. CONCLUSIONSThe identification of caffeine as a relevant factor in aging and healthspan in worms, combined with prior work in both humans and rodents linking caffeine consumption to reduced risk of age-associated disease, suggests that caffeine may target conserved longevity pathways. Further, it may be important to consider caffeine consumption when developing clinical interventions, particularly those designed to mimic dietary restriction or modulate insulin/IGF-1-like signaling. The positive impact of caffeine on a worm model of polyglutamine disease suggests that chronic caffeine consumption may generally enhance resistance to proteotoxic stress and may be relevant to assessing risk and developing treatments for human diseases like Alzheimer's and Huntington's disease. Future work addressing the relevant targets of caffeine in models of aging and healthspan will help to clarify the underlying mechanisms and potentially identify new molecular targets for disease intervention. Abstract Background The longevity of an organism is influenced by both genetic and environmental factors. With respect to genetic factors, a significant effort is being made to identify pharmacological agents that extend life span by targeting pathways with a defined role in the aging process. On the environmental side, the molecular mechanisms responsible for the positive influence of interventions such as dietary restriction are being explored. The environment experienced by humans in modern societies already contains countless compounds that may influence longevity. Understanding the role played by common compounds that substantially affect the aging process will be critical for predicting and interpreting the outcome of introducing new interventions. Caffeine is the most widely used psychoactive drug worldwide. Prior studies in flies, worms, and mice indicate that caffeine may positively impact age-associated neurodegenerative pathology, such as that observed in Alzheimer’s disease. Results Here we report that caffeine is capable of extending life span and improving healthspan in Caenorhabditis elegans , a finding that is in agreement with a recently published screen looking for FDA-approved compounds capable of extending worm life span. Life span extension using caffeine displays epistatic interaction with two known longevity interventions: dietary restriction and reduced insulin signaling. Caffeine treatment also delays pathology in a nematode model of polyglutamine disease. Conclusions The identification of caffeine as a relevant factor in aging and healthspan in worms, combined with prior work in both humans and rodents linking caffeine consumption to reduced risk of age-associated disease, suggests that caffeine may target conserved longevity pathways. Further, it may be important to consider caffeine consumption when developing clinical interventions, particularly those designed to mimic dietary restriction or modulate insulin/IGF-1-like signaling. The positive impact of caffeine on a worm model of polyglutamine disease suggests that chronic caffeine consumption may generally enhance resistance to proteotoxic stress and may be relevant to assessing risk and developing treatments for human diseases like Alzheimer’s and Huntington’s disease. Future work addressing the relevant targets of caffeine in models of aging and healthspan will help to clarify the underlying mechanisms and potentially identify new molecular targets for disease intervention. |
| ArticleNumber | 9 |
| Audience | Academic |
| Author | Kaeberlein, Matt Sutphin, George L Moller, Richard M Bishop, Emma Yanos, Melana E |
| AuthorAffiliation | 3 Department of Psychology, University of Washington, Box 351525, Seattle, 98195-1525, WA, USA 4 Institute of Aging Research, Guangdong Medical College, Dongguan, 523808, China 1 Department of Pathology, University of Washington, Box 357470, Seattle, 98195-7470, WA, USA 2 Molecular and Cellular Biology Program, University of Washington, Box 357275, Seattle, 98195-7275, WA, USA |
| AuthorAffiliation_xml | – name: 2 Molecular and Cellular Biology Program, University of Washington, Box 357275, Seattle, 98195-7275, WA, USA – name: 4 Institute of Aging Research, Guangdong Medical College, Dongguan, 523808, China – name: 3 Department of Psychology, University of Washington, Box 351525, Seattle, 98195-1525, WA, USA – name: 1 Department of Pathology, University of Washington, Box 357470, Seattle, 98195-7470, WA, USA |
| Author_xml | – sequence: 1 givenname: George L surname: Sutphin fullname: Sutphin, George L organization: Department of Pathology, University of Washington, Box 357470, Seattle, 98195-7470, WA, USA ; Molecular and Cellular Biology Program, University of Washington, Box 357275, Seattle, 98195-7275, WA, USA – sequence: 2 givenname: Emma surname: Bishop fullname: Bishop, Emma organization: Department of Pathology, University of Washington, Box 357470, Seattle, 98195-7470, WA, USA – sequence: 3 givenname: Melana E surname: Yanos fullname: Yanos, Melana E organization: Department of Pathology, University of Washington, Box 357470, Seattle, 98195-7470, WA, USA ; Department of Psychology, University of Washington, Box 351525, Seattle, 98195-1525, WA, USA – sequence: 4 givenname: Richard M surname: Moller fullname: Moller, Richard M organization: Department of Pathology, University of Washington, Box 357470, Seattle, 98195-7470, WA, USA – sequence: 5 givenname: Matt surname: Kaeberlein fullname: Kaeberlein, Matt organization: Department of Pathology, University of Washington, Box 357470, Seattle, 98195-7470, WA, USA ; Institute of Aging Research, Guangdong Medical College, Dongguan, 523808, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24764514$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1ktuL1TAQxoOsuOu6j75KQBAFuzZpensRl4OXhQVB9z1M02kbSZPatIvnvzelx8MpavKQ22--JN_MU3JmnUVCnrP4mrEie8djkUU8KdOIReUjcnFcn53Mz8mV9z_i0IpCMMGfkHMu8kykTFwQu4OmQW2R4q8Jbe2p0Q1SP4B9S3U_jO4BPe0QzNStm2BrWqOBvafQYgTeO6VhwpoOMHXOuHZPtaU7QOvGDqpaT9pTNNiC9c_I4waMx6vDeEnuP328332J7r5-vt3d3EWVKPIyEoyrLK7yGFKeVEmc5wJQqDJNKl43uUqyOBEiQ1B5XvCUQc7SOBUNZFDXWCSX5P0qO8xVj7VCO41g5DDqHsa9dKDl9sTqTrbuQSYl5yVbBD6sApV2_xHYnijXy8VxuTgumSyDxOvDG0b3c0Y_yV57hcaARTd7yVJW8iwWxXLbyxVtwaDUtnFBUy24vEnDR0sWDAnU9T-o0GvstQqF0eiwvwl4swkIzBSy3MLsvbz9_m3LvjphD_l2Zp60s34LRiuoRuf9iM3RFBbLpSj_suHFaSqO9J8STH4DfOTdDA |
| CitedBy_id | crossref_primary_10_1002_adbi_202400138 crossref_primary_10_1007_s12192_017_0824_7 crossref_primary_10_1590_1414_431x20187552 crossref_primary_10_1371_journal_pone_0082543 crossref_primary_10_1016_j_arr_2021_101443 crossref_primary_10_1007_s00394_022_02957_1 crossref_primary_10_3389_fnins_2018_00137 crossref_primary_10_3390_molecules26237323 crossref_primary_10_1017_erm_2023_18 crossref_primary_10_1155_2018_9241308 crossref_primary_10_14348_molcells_2016_2298 crossref_primary_10_1039_C5FO00463B crossref_primary_10_1038_s41598_018_27330_3 crossref_primary_10_1007_s13659_017_0135_9 crossref_primary_10_1007_s11357_021_00418_x crossref_primary_10_14348_molcells_2015_2282 crossref_primary_10_3390_medicines4030061 crossref_primary_10_1016_j_bbrc_2023_149240 crossref_primary_10_1007_s11357_024_01262_5 crossref_primary_10_1089_rej_2015_1774 crossref_primary_10_3390_molecules20046544 crossref_primary_10_1111_acel_12595 crossref_primary_10_3389_fnagi_2018_00211 crossref_primary_10_1080_13880209_2020_1791192 crossref_primary_10_3389_fcell_2020_00822 crossref_primary_10_1093_hmg_ddab296 crossref_primary_10_1016_j_heliyon_2020_e04886 crossref_primary_10_1016_j_tma_2018_08_002 crossref_primary_10_3390_nu12113348 crossref_primary_10_1021_acschemneuro_5b00158 crossref_primary_10_1016_j_ejphar_2017_11_051 crossref_primary_10_1016_j_neurobiolaging_2021_05_020 crossref_primary_10_3390_foods10061404 crossref_primary_10_3390_molecules23061359 crossref_primary_10_3389_fnagi_2015_00220 crossref_primary_10_3390_nu12082440 crossref_primary_10_1016_j_tem_2019_04_001 crossref_primary_10_1093_gerona_glad086 crossref_primary_10_3390_nu13082517 crossref_primary_10_3390_ijms21249510 crossref_primary_10_1007_s11357_017_9988_4 crossref_primary_10_1007_s11357_016_9936_8 crossref_primary_10_1021_jf503120j crossref_primary_10_3390_biomedicines10061258 crossref_primary_10_3390_cells10092481 crossref_primary_10_1016_j_exger_2016_11_008 crossref_primary_10_1007_s11357_018_0036_9 crossref_primary_10_1080_1028415X_2019_1671694 crossref_primary_10_3390_nu12051334 crossref_primary_10_1007_s10522_021_09941_y crossref_primary_10_1080_1028415X_2018_1517473 crossref_primary_10_1016_j_fochx_2019_100005 |
| Cites_doi | 10.1111/j.1474-9726.2009.00533.x 10.1073/pnas.92.20.9368 10.1038/nn.2540 10.1002/bies.200900171 10.1111/j.1474-9726.2011.00702.x 10.2337/diacare.25.2.364 10.1007/s00213-008-1294-5 10.1002/hup.218 10.1111/j.1474-9726.2011.00672.x 10.1016/j.expneurol.2006.08.008 10.1073/pnas.95.22.13091 10.3233/JAD-2010-091525 10.1016/j.neuroscience.2008.03.038 10.1177/1533317508320083 10.1523/JNEUROSCI.3728-09.2009 10.1038/nature08980 10.3233/JAD-2009-1071 10.1016/j.expneurol.2007.11.013 10.1093/ajcn/87.5.1254 10.1371/journal.pone.0027762 10.2337/diacare.29.02.06.dc05-1512 10.1126/science.1172539 10.1093/aje/kwf074 10.1111/j.1365-2958.2006.05300.x 10.1111/j.1471-4159.1975.tb04424.x 10.1111/j.1474-9726.2011.00742.x 10.1093/aje/kwf119 10.1161/01.RES.0000256354.95791.f1 10.1016/j.pharmthera.2008.10.006 10.3233/JAD-2010-1404 10.1371/journal.pone.0028036 10.3233/JAD-2010-091303 10.1111/j.1474-9726.2006.00236.x 10.1111/j.1474-9726.2006.00238.x 10.1016/S0021-9258(17)32357-8 10.1017/S0007114511002406 10.1001/jama.283.20.2674 10.1016/j.neurobiolaging.2004.08.012 10.1111/j.1474-9726.2006.00241.x 10.1101/gr.2505604 10.1001/jama.294.1.97 10.1212/WNL.55.9.1350 10.1016/j.febslet.2012.07.038 10.1111/j.1474-9726.2006.00202.x 10.1016/j.ypmed.2006.12.011 10.1056/NEJMoa1112010 10.1046/j.1468-1331.2002.00421.x 10.1097/00001648-200007000-00013 10.1534/genetics.110.120436 10.1126/science.1173507 10.3233/JAD-2010-1408 10.1016/S0197-4580(02)00224-5 10.1111/j.1474-9726.2008.00385.x 10.1016/S0361-9230(01)00501-9 10.1016/j.neuroscience.2006.07.021 10.1111/j.1365-2958.2008.06292.x 10.1038/sj.ejcn.1602495 10.3233/JAD-2009-1087 10.1016/j.exger.2010.04.008 10.1016/j.neuron.2005.11.008 10.3233/JAD-2010-091387 10.1186/1471-213X-8-49 10.1002/ana.1052 10.1212/01.wnl.0000266670.35219.0c 10.1093/genetics/133.4.897 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2012 BioMed Central Ltd. Copyright © 2012 Sutphin et al.; licensee BioMed Central Ltd. 2012 Sutphin et al.; licensee BioMed Central Ltd. |
| Copyright_xml | – notice: COPYRIGHT 2012 BioMed Central Ltd. – notice: Copyright © 2012 Sutphin et al.; licensee BioMed Central Ltd. 2012 Sutphin et al.; licensee BioMed Central Ltd. |
| DBID | NPM AAYXX CITATION ISR 7X8 5PM |
| DOI | 10.1186/2046-2395-1-9 |
| DatabaseName | PubMed CrossRef Gale In Context: Science MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 2046-2395 |
| EndPage | 9 |
| ExternalDocumentID | oai_biomedcentral_com_2046_2395_1_9 A534491412 10_1186_2046_2395_1_9 24764514 |
| Genre | Journal Article |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GrantInformation_xml | – fundername: NIA NIH HHS grantid: R01 AG031108 – fundername: NIA NIH HHS grantid: P01 AG001751 – fundername: NIA NIH HHS grantid: T32 AG000057 – fundername: NIA NIH HHS grantid: R01 AG038518 |
| GroupedDBID | -A0 4.4 ACGFS ACRMQ ADBBV ADINQ ADUKV AHBYD AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BAWUL BFQNJ BMC C24 C6C DIK EBS EJD GX1 HYE IAO IHR IHW ISR ITC KQ8 M~E NPM OK1 PGMZT RBZ ROL RPM RSV SMD SOJ AAYXX CITATION AFGXO 7X8 ABVAZ AFNRJ 5PM |
| ID | FETCH-LOGICAL-b4879-412c60b70a523b30774ae4c953b2df7c3603446eac778251a715054fa6adde83 |
| IEDL.DBID | RBZ |
| ISSN | 2046-2395 |
| IngestDate | Tue Sep 17 21:15:14 EDT 2024 Wed May 22 07:14:56 EDT 2024 Sat Oct 26 01:29:48 EDT 2024 Wed Aug 14 18:52:25 EDT 2024 Tue Aug 13 05:23:06 EDT 2024 Sat Sep 28 21:32:55 EDT 2024 Tue Aug 13 02:41:19 EDT 2024 Thu Sep 12 18:47:40 EDT 2024 Sat Sep 28 08:23:53 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Life span Neurodegeneration Proteotoxicity Aging Healthspan Longevity Worms Caffeine |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b4879-412c60b70a523b30774ae4c953b2df7c3603446eac778251a715054fa6adde83 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | http://dx.doi.org/10.1186/2046-2395-1-9 |
| PMID | 24764514 |
| PQID | 1519260488 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3922918 biomedcentral_primary_oai_biomedcentral_com_2046_2395_1_9 proquest_miscellaneous_1519260488 gale_infotracmisc_A534491412 gale_infotracacademiconefile_A534491412 gale_incontextgauss_ISR_A534491412 gale_healthsolutions_A534491412 crossref_primary_10_1186_2046_2395_1_9 pubmed_primary_24764514 |
| PublicationCentury | 2000 |
| PublicationDate | 20121201 |
| PublicationDateYYYYMMDD | 2012-12-01 |
| PublicationDate_xml | – month: 12 year: 2012 text: 20121201 day: 1 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Longevity & healthspan |
| PublicationTitleAlternate | Longev Healthspan |
| PublicationYear | 2012 |
| Publisher | BioMed Central Ltd BioMed Central |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central |
| References | FR Butcher (9_CR61) 1972; 32 J Tsuzuki (9_CR62) 1975; 25 B Lakowski (9_CR50) 1998; 95 GW Arendash (9_CR32) 2009; 17 RD Prediger (9_CR34) 2005; 26 C Santos (9_CR18) 2010; 20 GL Sutphin (9_CR65) 2009; 27 BA Rikke (9_CR5) 2010; 45 C Cao (9_CR28) 2009; 17 BB Fredholm (9_CR8) 1999; 51 BM van Gelder (9_CR19) 2007; 61 L Maia (9_CR11) 2002; 9 GW Arendash (9_CR27) 2006; 142 A Ascherio (9_CR12) 2001; 50 JR Delaney (9_CR57) 2011; 10 RA Cunha (9_CR25) 2010; 20 CY Liao (9_CR3) 2010; 9 J Costa (9_CR14) 2010; 20 R Mehta (9_CR51) 2009; 324 SF Leiser (9_CR39) 2011; 10 MD Benedetti (9_CR13) 2000; 55 TL Kaeberlein (9_CR46) 2006; 5 CJ Kenyon (9_CR2) 2010; 464 CD Link (9_CR42) 1995; 92 J Lindsay (9_CR10) 2002; 156 JM Harper (9_CR7) 2006; 5 MS Gevaerd (9_CR26) 2001; 55 KA Steinkraus (9_CR68) 2008; 7 CY Liao (9_CR4) 2011; 10 A Rosso (9_CR23) 2008; 23 J Schleit (9_CR6) 2012; 586 LL Moisey (9_CR54) 2008; 87 GD Lee (9_CR48) 2006; 5 M Johnson-Kozlow (9_CR21) 2002; 156 MJ Spinetta (9_CR58) 2008; 201 J Sun (9_CR41) 1994; 269 MH Eskelinen (9_CR9) 2010; 20 A Paganini-Hill (9_CR17) 2007; 44 L Fontana (9_CR1) 2010; 328 RM van Dam (9_CR55) 2005; 294 K Ritchie (9_CR22) 2007; 69 K Omori (9_CR60) 2007; 100 V Dostal (9_CR36) 2010; 186 GW Ross (9_CR15) 2000; 283 C Fortes (9_CR16) 2000; 11 C Santos (9_CR24) 2010; 20 SV Conde (9_CR56) 2012; 107 DK Ingram (9_CR45) 2006; 5 CD Link (9_CR35) 2003; 24 NM Bonini (9_CR43) 2005; 48 M Kaeberlein (9_CR44) 2010; 32 J Schleit (9_CR67) 2011; 6 PM Canas (9_CR29) 2009; 29 RM van Dam (9_CR63) 2006; 29 ND Freedman (9_CR64) 2012; 366 GM Cunha (9_CR30) 2008; 210 A Lublin (9_CR37) 2011; 6 V Wanke (9_CR38) 2008; 69 L Avery (9_CR49) 1993; 133 GB Keijzers (9_CR53) 2002; 25 J Liu (9_CR59) 2010; 13 K Kuranda (9_CR40) 2006; 61 JF Rual (9_CR66) 2004; 14 MS Costa (9_CR33) 2008; 153 NP Riksen (9_CR52) 2009; 121 ED Smith (9_CR47) 2008; 8 OP Dall'Igna (9_CR31) 2007; 203 PA Hameleers (9_CR20) 2000; 15 |
| References_xml | – volume: 9 start-page: 92 year: 2010 ident: 9_CR3 publication-title: Aging Cell doi: 10.1111/j.1474-9726.2009.00533.x contributor: fullname: CY Liao – volume: 92 start-page: 9368 year: 1995 ident: 9_CR42 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.92.20.9368 contributor: fullname: CD Link – volume: 13 start-page: 715 year: 2010 ident: 9_CR59 publication-title: Nat Neurosci doi: 10.1038/nn.2540 contributor: fullname: J Liu – volume: 32 start-page: 96 year: 2010 ident: 9_CR44 publication-title: Bioessays doi: 10.1002/bies.200900171 contributor: fullname: M Kaeberlein – volume: 10 start-page: 629 year: 2011 ident: 9_CR4 publication-title: Aging Cell doi: 10.1111/j.1474-9726.2011.00702.x contributor: fullname: CY Liao – volume: 25 start-page: 364 year: 2002 ident: 9_CR53 publication-title: Diabetes Care doi: 10.2337/diacare.25.2.364 contributor: fullname: GB Keijzers – volume: 201 start-page: 361 year: 2008 ident: 9_CR58 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1294-5 contributor: fullname: MJ Spinetta – volume: 15 start-page: 573 year: 2000 ident: 9_CR20 publication-title: Hum Psychopharmacol doi: 10.1002/hup.218 contributor: fullname: PA Hameleers – volume: 10 start-page: 318 year: 2011 ident: 9_CR39 publication-title: Aging Cell doi: 10.1111/j.1474-9726.2011.00672.x contributor: fullname: SF Leiser – volume: 203 start-page: 241 year: 2007 ident: 9_CR31 publication-title: Exp Neurol doi: 10.1016/j.expneurol.2006.08.008 contributor: fullname: OP Dall'Igna – volume: 95 start-page: 13091 year: 1998 ident: 9_CR50 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.95.22.13091 contributor: fullname: B Lakowski – volume: 20 start-page: S221 issue: Suppl 1 year: 2010 ident: 9_CR14 publication-title: J Alzheimers Dis doi: 10.3233/JAD-2010-091525 contributor: fullname: J Costa – volume: 153 start-page: 1071 year: 2008 ident: 9_CR33 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2008.03.038 contributor: fullname: MS Costa – volume: 23 start-page: 417 year: 2008 ident: 9_CR23 publication-title: Am J Alzheimers Dis Other Demen doi: 10.1177/1533317508320083 contributor: fullname: A Rosso – volume: 29 start-page: 14741 year: 2009 ident: 9_CR29 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.3728-09.2009 contributor: fullname: PM Canas – volume: 464 start-page: 504 year: 2010 ident: 9_CR2 publication-title: Nature doi: 10.1038/nature08980 contributor: fullname: CJ Kenyon – volume: 17 start-page: 681 year: 2009 ident: 9_CR28 publication-title: J Alzheimers Dis doi: 10.3233/JAD-2009-1071 contributor: fullname: C Cao – volume: 210 start-page: 776 year: 2008 ident: 9_CR30 publication-title: Exp Neurol doi: 10.1016/j.expneurol.2007.11.013 contributor: fullname: GM Cunha – volume: 87 start-page: 1254 year: 2008 ident: 9_CR54 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/87.5.1254 contributor: fullname: LL Moisey – volume: 6 start-page: e27762 year: 2011 ident: 9_CR37 publication-title: PLoS One doi: 10.1371/journal.pone.0027762 contributor: fullname: A Lublin – volume: 29 start-page: 398 year: 2006 ident: 9_CR63 publication-title: Diabetes Care doi: 10.2337/diacare.29.02.06.dc05-1512 contributor: fullname: RM van Dam – volume: 328 start-page: 321 year: 2010 ident: 9_CR1 publication-title: Science doi: 10.1126/science.1172539 contributor: fullname: L Fontana – volume: 156 start-page: 445 year: 2002 ident: 9_CR10 publication-title: Am J Epidemiol doi: 10.1093/aje/kwf074 contributor: fullname: J Lindsay – volume: 61 start-page: 1147 year: 2006 ident: 9_CR40 publication-title: Mol Microbiol doi: 10.1111/j.1365-2958.2006.05300.x contributor: fullname: K Kuranda – volume: 25 start-page: 895 year: 1975 ident: 9_CR62 publication-title: J Neurochem doi: 10.1111/j.1471-4159.1975.tb04424.x contributor: fullname: J Tsuzuki – volume: 10 start-page: 1089 year: 2011 ident: 9_CR57 publication-title: Aging Cell doi: 10.1111/j.1474-9726.2011.00742.x contributor: fullname: JR Delaney – volume: 32 start-page: 2141 year: 1972 ident: 9_CR61 publication-title: Cancer Res contributor: fullname: FR Butcher – volume: 27 start-page: e1152 year: 2009 ident: 9_CR65 publication-title: J Vis Exp contributor: fullname: GL Sutphin – volume: 156 start-page: 842 year: 2002 ident: 9_CR21 publication-title: Am J Epidemiol doi: 10.1093/aje/kwf119 contributor: fullname: M Johnson-Kozlow – volume: 100 start-page: 309 year: 2007 ident: 9_CR60 publication-title: Circ Res doi: 10.1161/01.RES.0000256354.95791.f1 contributor: fullname: K Omori – volume: 51 start-page: 83 year: 1999 ident: 9_CR8 publication-title: Pharmacol Rev contributor: fullname: BB Fredholm – volume: 121 start-page: 185 year: 2009 ident: 9_CR52 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2008.10.006 contributor: fullname: NP Riksen – volume: 20 start-page: S167 issue: Suppl 1 year: 2010 ident: 9_CR9 publication-title: J Alzheimers Dis doi: 10.3233/JAD-2010-1404 contributor: fullname: MH Eskelinen – volume: 6 start-page: e28036 year: 2011 ident: 9_CR67 publication-title: PLoS One doi: 10.1371/journal.pone.0028036 contributor: fullname: J Schleit – volume: 20 start-page: S175 issue: Suppl 1 year: 2010 ident: 9_CR18 publication-title: J Alzheimers Dis doi: 10.3233/JAD-2010-091303 contributor: fullname: C Santos – volume: 5 start-page: 441 year: 2006 ident: 9_CR7 publication-title: Aging Cell doi: 10.1111/j.1474-9726.2006.00236.x contributor: fullname: JM Harper – volume: 5 start-page: 487 year: 2006 ident: 9_CR46 publication-title: Aging Cell doi: 10.1111/j.1474-9726.2006.00238.x contributor: fullname: TL Kaeberlein – volume: 269 start-page: 18638 year: 1994 ident: 9_CR41 publication-title: J Biol Chem doi: 10.1016/S0021-9258(17)32357-8 contributor: fullname: J Sun – volume: 107 start-page: 86 year: 2012 ident: 9_CR56 publication-title: Br J Nutr doi: 10.1017/S0007114511002406 contributor: fullname: SV Conde – volume: 283 start-page: 2674 year: 2000 ident: 9_CR15 publication-title: Jama doi: 10.1001/jama.283.20.2674 contributor: fullname: GW Ross – volume: 26 start-page: 957 year: 2005 ident: 9_CR34 publication-title: Neurobiol Aging doi: 10.1016/j.neurobiolaging.2004.08.012 contributor: fullname: RD Prediger – volume: 5 start-page: 515 year: 2006 ident: 9_CR48 publication-title: Aging Cell doi: 10.1111/j.1474-9726.2006.00241.x contributor: fullname: GD Lee – volume: 14 start-page: 2162 year: 2004 ident: 9_CR66 publication-title: Genome Res doi: 10.1101/gr.2505604 contributor: fullname: JF Rual – volume: 294 start-page: 97 year: 2005 ident: 9_CR55 publication-title: Jama doi: 10.1001/jama.294.1.97 contributor: fullname: RM van Dam – volume: 55 start-page: 1350 year: 2000 ident: 9_CR13 publication-title: Neurology doi: 10.1212/WNL.55.9.1350 contributor: fullname: MD Benedetti – volume: 586 start-page: 2868 year: 2012 ident: 9_CR6 publication-title: FEBS Lett doi: 10.1016/j.febslet.2012.07.038 contributor: fullname: J Schleit – volume: 5 start-page: 97 year: 2006 ident: 9_CR45 publication-title: Aging Cell doi: 10.1111/j.1474-9726.2006.00202.x contributor: fullname: DK Ingram – volume: 44 start-page: 305 year: 2007 ident: 9_CR17 publication-title: Prev Med doi: 10.1016/j.ypmed.2006.12.011 contributor: fullname: A Paganini-Hill – volume: 366 start-page: 1891 year: 2012 ident: 9_CR64 publication-title: N Engl J Med doi: 10.1056/NEJMoa1112010 contributor: fullname: ND Freedman – volume: 9 start-page: 377 year: 2002 ident: 9_CR11 publication-title: Eur J Neurol doi: 10.1046/j.1468-1331.2002.00421.x contributor: fullname: L Maia – volume: 11 start-page: 440 year: 2000 ident: 9_CR16 publication-title: Epidemiology doi: 10.1097/00001648-200007000-00013 contributor: fullname: C Fortes – volume: 186 start-page: 857 year: 2010 ident: 9_CR36 publication-title: Genetics doi: 10.1534/genetics.110.120436 contributor: fullname: V Dostal – volume: 324 start-page: 1196 year: 2009 ident: 9_CR51 publication-title: Science doi: 10.1126/science.1173507 contributor: fullname: R Mehta – volume: 20 start-page: S95 issue: Suppl 1 year: 2010 ident: 9_CR25 publication-title: J Alzheimers Dis doi: 10.3233/JAD-2010-1408 contributor: fullname: RA Cunha – volume: 24 start-page: 397 year: 2003 ident: 9_CR35 publication-title: Neurobiol Aging doi: 10.1016/S0197-4580(02)00224-5 contributor: fullname: CD Link – volume: 7 start-page: 394 year: 2008 ident: 9_CR68 publication-title: Aging Cell doi: 10.1111/j.1474-9726.2008.00385.x contributor: fullname: KA Steinkraus – volume: 55 start-page: 101 year: 2001 ident: 9_CR26 publication-title: Brain Res Bull doi: 10.1016/S0361-9230(01)00501-9 contributor: fullname: MS Gevaerd – volume: 142 start-page: 941 year: 2006 ident: 9_CR27 publication-title: Neuroscience doi: 10.1016/j.neuroscience.2006.07.021 contributor: fullname: GW Arendash – volume: 69 start-page: 277 year: 2008 ident: 9_CR38 publication-title: Mol Microbiol doi: 10.1111/j.1365-2958.2008.06292.x contributor: fullname: V Wanke – volume: 61 start-page: 226 year: 2007 ident: 9_CR19 publication-title: Eur J Clin Nutr doi: 10.1038/sj.ejcn.1602495 contributor: fullname: BM van Gelder – volume: 17 start-page: 661 year: 2009 ident: 9_CR32 publication-title: J Alzheimers Dis doi: 10.3233/JAD-2009-1087 contributor: fullname: GW Arendash – volume: 45 start-page: 691 year: 2010 ident: 9_CR5 publication-title: Exp Gerontol doi: 10.1016/j.exger.2010.04.008 contributor: fullname: BA Rikke – volume: 48 start-page: 715 year: 2005 ident: 9_CR43 publication-title: Neuron doi: 10.1016/j.neuron.2005.11.008 contributor: fullname: NM Bonini – volume: 20 start-page: S187 issue: Suppl 1 year: 2010 ident: 9_CR24 publication-title: J Alzheimers Dis doi: 10.3233/JAD-2010-091387 contributor: fullname: C Santos – volume: 8 start-page: 49 year: 2008 ident: 9_CR47 publication-title: BMC Dev Biol doi: 10.1186/1471-213X-8-49 contributor: fullname: ED Smith – volume: 50 start-page: 56 year: 2001 ident: 9_CR12 publication-title: Ann Neurol doi: 10.1002/ana.1052 contributor: fullname: A Ascherio – volume: 69 start-page: 536 year: 2007 ident: 9_CR22 publication-title: Neurology doi: 10.1212/01.wnl.0000266670.35219.0c contributor: fullname: K Ritchie – volume: 133 start-page: 897 year: 1993 ident: 9_CR49 publication-title: Genetics doi: 10.1093/genetics/133.4.897 contributor: fullname: L Avery |
| SSID | ssj0000884142 |
| Score | 1.8644817 |
| Snippet | The longevity of an organism is influenced by both genetic and environmental factors. With respect to genetic factors, a significant effort is being made to... Abstract Background The longevity of an organism is influenced by both genetic and environmental factors. With respect to genetic factors, a significant effort... Background The longevity of an organism is influenced by both genetic and environmental factors. With respect to genetic factors, a significant effort is being... BACKGROUNDThe longevity of an organism is influenced by both genetic and environmental factors. With respect to genetic factors, a significant effort is being... BACKGROUND: The longevity of an organism is influenced by both genetic and environmental factors. With respect to genetic factors, a significant effort is... |
| SourceID | pubmedcentral biomedcentral proquest gale crossref pubmed |
| SourceType | Open Access Repository Aggregation Database Index Database |
| StartPage | 9 |
| SubjectTerms | Aging Alzheimer's disease Analysis Animal experimentation Caenorhabditis elegans Caffeine Drug approval Hallucinogenic drugs Health aspects Longevity Nematoda Type 2 diabetes |
| SummonAdditionalLinks | – databaseName: PubMed Central dbid: RPM link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbanpAQAsojUKhBCC6ku3FsJzlWq1YFqQhBkXqzbMehkbbequke-PfM2Em13mOv8ViyPW9n5jMhn7QVjknd5swUOudW1rkWnc4Zr0pTOqNtKPk__yHP_vDvl-Jyh4ipFyYU7VvTH_nl9ZHvr0Jt5c21nU11YrOf5wvw6awp6tku2QUB3UjRg_mta15wNuFp1hLyey5zVjYC0iVECYV1SC6K7R73ZeKatg30hodKqyc33NHpU_JkjCPpcVzvM7Lj_HPyOF7C0dhbtE_8QnedgziSxrvugS77zlEwIv4r7cN1ghtobIWMH7VvKeJG_hsoGJpcj8xzLcWni8MVPO09XWjnV7dX2rQIiUTx7QpweS_IxenJxeIsHx9YyA3kKfgHmFk5N9VcQzpqQNsrrh23jSgNa7vKlhIBAaVDhmGLq64gfBS80xKtYl2-JHt-5d1rQoVszdwIKwzot2OsNoLrljvLiw4h6zPSJEetbiKWhkJ063QEFE0hxxRyTBWqycjniS3300LqUsttwkNkmhqPbVJddSxgF00Bu83Ix0CBwBceK2v-6vUwqG-_fyVEX0aibgUrsnpsVICdIlZWQnmQUIJm2mT4wyQ9CoewnM271XpQEGY1kEiC8czIqyhN91ubpDMjVSJnyZGlI6AnARh81Is3D575ljyCgJDFcp0Dsnd3u3bvIOi6M--Dkv0HqcAuJA priority: 500 providerName: National Library of Medicine |
| Title | Caffeine extends life span, improves healthspan, and delays age-associated pathology in Caenorhabditis elegans |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/24764514 https://search.proquest.com/docview/1519260488 http://dx.doi.org/10.1186/2046-2395-1-9 https://pubmed.ncbi.nlm.nih.gov/PMC3922918 |
| Volume | 1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9UwDI_YuCAhBOOrsL0FhOBCpdc0Sdvj9rRpII0DDGniEjlpyp405aF178CFvx077XssvXJt3KqxY8d27F8YewdOeaGhzYUtIJdO1zmoDnIhq9KW3oKLJf_nX_TZd_n5Ul3-A0manOAXtcboXOpclI3CYKfZYfcF4alQWH78Y5tMQVWRRbwoZ0u9wdOcfmHS2H6d7EdTq3xnW0pLJu_sQaeP2aPReeRHg7SfsHs-7LGHQ-aNDw1FT1lYQNd5dB75kODu-fWy8xwtR_jIlzGH4Hs-9D8ODyG0nMAif_ccrUsOo8R8y-m-4ph358vAF-DD6uYKbEs4SJwurMB97hm7OD25WJzl460KucXghI59hdNzW80BY1CLKl5J8NI1qrSi7SpXakIB1J6kRH2tUKHPqGQHmkxhXT5nu2EV_EvGlW7t3CqnLCq1F6K2SkIrvZNFRzj1GWsSVptfA4CGIUjrdAS1y5CYDInJFKbJ2PuNWLavxXil1lPCQxKaGdm20VdzpHAWTYGzzdjbSEFoF4HKaX7Cuu_Np29fE6IPI1G3wj9yMHYn4EwJICuh3E8oUR1dMvxms3oMDVENW_CrdW_Qt2owekSLmbEXw2raTg1VQ0v0XTNWJessYVk6EpZXEQ0cHVzRFPWr_2D2a_YA_UAxVOnss93bm7U_QF_r1s7Yzvmfk1nUtllMhf0F5JgpSA |
| link.rule.ids | 108,230,315,730,783,787,888,24949,27936,27937,53804,53806,76146,76147 |
| linkProvider | BioMedCentral |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9QwDI9gPICEJr7pGCwgBC_rdE2TtH0cJ6YbbHsYhzTxEiVpup10StG6e-C_x07b43KvPMetGjt2bNf-mZCP2grHpK5TZjKdcivLVItGp4wXucmd0TaU_J9fyNlP_u1KXA3t0WHUV-uvHU5N6NsAQav80WYj-jJY77ForNf5UkIIz2XK8kpARFTdJw8gOOcYil1--bXOuIA-8SxM01lTj6Cb22_Y6n5fRpfWtuneuLviusqNi-rkCdkdPEx63H_8U3LP-WfkcZ-eo33X0XPip7ppHHiYtM-Cd3S5aBxFRhzSRUg0uI7-484h1b6miCj5p6NgglI9iNXVFIcah-Q8XXg61c63tzfa1AiWRHGqBVyGL8j85Ot8OkuH0QupgQgG_w0zKyemmGgIVA3YgYJrx20lcsPqprC5RKhA6VCU2PyqC3AsBW-0RHtZ5i_Jjm-9e02okLWZGGGFAc13jJVGcF1zZ3nWIJh9QqqI1ep3j7KhEPc6XgHJKxSTQjGpTFUJ-TSKZf1YCGpKuU14gEJTA9tGpVbHAnZRZbDbhHwIFAiJ4bHm5lqvuk6d_riMiD4PRE0LX2T10MIAO0UUrYhyP6IEnbXR8vvx9ChcwkI379pVp8ABqyDEBLOakFf9aVpvDfRHcnBwE1JE5yxiWbziFzcBMhy8YFZl5d5_MPuAPJzNz8_U2enF9zfkETiOrC_r2Sc7d7cr9xacszvzLujcXzREOU0 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LbxMxELZKkRASQrxZKNQgBJcuZL22d_dYAlELtEKlSBUXy_babUTkrbrNgX_PzD5CnCu3SJ5E8rw8M5n5hpA32grHpK5TZjKdcivLVAuvU8aL3OTOaNu1_B8dy4Of_MuZONsiR-MszKIJ5w63JvRjgGBV4f36IPqi897wwf7-cFn73uhLCTk8lynLKwEpUXWD3ITsnKPCn3z8tSq5gEHxrFuns6IeUTc3f2Fj_H0RvVqbvnvt8YobK9deqtk9cncIMel-rxP3yZYLD8idvj5H-7GjhyRMtfcOQkzal8Fbuph7R5ETe3TeVRpcS_-xZ4_qUFOElPzTUvBBqR7k6mqKW4276jydBzrVLjRXF9rUiJZEca0FvIaPyOns8-n0IB12L6QGUhj8c5hZOTHFREOmasARFFw7biuRG1b7wuYSsQKlQ1ni9KsuILIU3GuJDrPMH5Pt0AT3lFAhazMxwgoDpu8YK43guubO8swjmn1CqojV6rKH2VAIfB2fgOgVikmhmFSmqoS8HcWy-lqX1ZRyk3AXhaYGto1WrfYF3KLK4LYJed1RICZGwKabc71sW3X44yQiejcQ-QZ1UA8zDHBThNGKKHciSjBaGx2_GrVH4RF2ugXXLFsFEVgFOSb41YQ86bVpdTUwIMkhwk1IEelZxLL4JMwvOsxwCINZlZXP_oPZu-TW908z9e3w-OtzchsCR9a39eyQ7eurpXsBwdm1edmZ3F-kPjkY |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Caffeine+extends+life+span%2C+improves+healthspan%2C+and+delays+age-associated+pathology+in+Caenorhabditis+elegans&rft.jtitle=Longevity+%26+healthspan&rft.au=Sutphin%2C+George+L&rft.au=Bishop%2C+Emma&rft.au=Yanos%2C+Melana+E&rft.au=Moller%2C+Richard+M&rft.date=2012-12-01&rft.issn=2046-2395&rft.eissn=2046-2395&rft.volume=1&rft.spage=9&rft_id=info:doi/10.1186%2F2046-2395-1-9&rft_id=info%3Apmid%2F24764514&rft.externalDocID=24764514 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2046-2395&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2046-2395&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2046-2395&client=summon |